219 related articles for article (PubMed ID: 11421579)
1. Metallothionein treatment reduces proinflammatory cytokines IL-6 and TNF-alpha and apoptotic cell death during experimental autoimmune encephalomyelitis (EAE).
Penkowa M; Hidalgo J
Exp Neurol; 2001 Jul; 170(1):1-14. PubMed ID: 11421579
[TBL] [Abstract][Full Text] [Related]
2. Metallothionein I+II expression and their role in experimental autoimmune encephalomyelitis.
Penkowa M; Hidalgo J
Glia; 2000 Dec; 32(3):247-63. PubMed ID: 11102966
[TBL] [Abstract][Full Text] [Related]
3. Involvement of Src-suppressed C kinase substrate in experimental autoimmune encephalomyelitis: a link between release of astrocyte proinflammatory factor and oligodendrocyte apoptosis.
Li X; Yan M; Hu L; Sun L; Zhang F; Ji H; Jiang J; Wang P; Liu H; Gao Y; Tao T; He X; Cheng C; Shen A
J Neurosci Res; 2010 Jul; 88(9):1858-71. PubMed ID: 20155814
[TBL] [Abstract][Full Text] [Related]
4. Effects of intravenous immunoglobulins on T cell and oligodendrocyte apoptosis in high-dose antigen therapy in experimental autoimmune encephalomyelitis.
Weishaupt A; Kuhlmann T; Schönrock LM; Toyka KV; Brück W; Gold R
Acta Neuropathol; 2002 Oct; 104(4):385-90. PubMed ID: 12200625
[TBL] [Abstract][Full Text] [Related]
5. Astrocyte-targeted expression of interleukin-6 protects the central nervous system during neuroglial degeneration induced by 6-aminonicotinamide.
Penkowa M; Camats J; Hadberg H; Quintana A; Rojas S; Giralt M; Molinero A; Campbell IL; Hidalgo J
J Neurosci Res; 2003 Aug; 73(4):481-96. PubMed ID: 12898533
[TBL] [Abstract][Full Text] [Related]
6. Propentofylline and iloprost suppress the production of TNF-alpha by macrophages but fail to ameliorate experimental autoimmune encephalomyelitis in Lewis rats.
Jung S; Donhauser T; Toyka KV; Hartung HP
J Autoimmun; 1997 Dec; 10(6):519-29. PubMed ID: 9451591
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis.
Kanwar JR; Kanwar RK; Krissansen GW
Brain; 2004 Jun; 127(Pt 6):1313-31. PubMed ID: 15130951
[TBL] [Abstract][Full Text] [Related]
8. Methylthioadenosine reverses brain autoimmune disease.
Moreno B; Hevia H; Santamaria M; Sepulcre J; Muñoz J; García-Trevijano ER; Berasain C; Corrales FJ; Avila MA; Villoslada P
Ann Neurol; 2006 Sep; 60(3):323-34. PubMed ID: 16786535
[TBL] [Abstract][Full Text] [Related]
9. Interferon alpha induction of metallothionein in rat liver is not linked to interleukin-1, interleukin-6, or tumor necrosis factor alpha.
Guevara-Ortiz JM; Omar-Castellanos V; León-Chávez BA; Achanzar WE; Brambila E
Exp Mol Pathol; 2005 Aug; 79(1):33-8. PubMed ID: 16005709
[TBL] [Abstract][Full Text] [Related]
10. Experimental autoimmune encephalomyelitis-induced upregulation of tumor necrosis factor-alpha in the dorsal root ganglia.
Melanson M; Miao P; Eisenstat D; Gong Y; Gu X; Au K; Zhu W; Begum F; Frost EE; Namaka M
Mult Scler; 2009 Oct; 15(10):1135-45. PubMed ID: 19667008
[TBL] [Abstract][Full Text] [Related]
11. Combined treatment of acute EAE in Lewis rats with TNF-binding protein and interleukin-1 receptor antagonist.
Wiemann B; Van GY; Danilenko DM; Yan Q; Matheson C; Munyakazi L; Ogenstad S; Starnes CO
Exp Neurol; 1998 Feb; 149(2):455-63. PubMed ID: 9500957
[TBL] [Abstract][Full Text] [Related]
12. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates experimental autoimmune encephalomyelitis via modulation of endothelial-monocyte interaction.
Prasad R; Giri S; Nath N; Singh I; Singh AK
J Neurosci Res; 2006 Aug; 84(3):614-25. PubMed ID: 16770773
[TBL] [Abstract][Full Text] [Related]
13. High IL-6 and low IL-10 in the central nervous system are associated with protracted relapsing EAE in DA rats.
Diab A; Zhu J; Xiao BG; Mustafa M; Link H
J Neuropathol Exp Neurol; 1997 Jun; 56(6):641-50. PubMed ID: 9184655
[TBL] [Abstract][Full Text] [Related]
14. Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis.
Morini M; Roccatagliata L; Dell'Eva R; Pedemonte E; Furlan R; Minghelli S; Giunti D; Pfeffer U; Marchese M; Noonan D; Mancardi G; Albini A; Uccelli A
J Neuroimmunol; 2004 Mar; 148(1-2):146-53. PubMed ID: 14975595
[TBL] [Abstract][Full Text] [Related]
15. Altered inflammatory response and increased neurodegeneration in metallothionein I+II deficient mice during experimental autoimmune encephalomyelitis.
Penkowa M; Espejo C; Martínez-Cáceres EM; Poulsen CB; Montalban X; Hidalgo J
J Neuroimmunol; 2001 Oct; 119(2):248-60. PubMed ID: 11585628
[TBL] [Abstract][Full Text] [Related]
16. Treatment with metallothionein prevents demyelination and axonal damage and increases oligodendrocyte precursors and tissue repair during experimental autoimmune encephalomyelitis.
Penkowa M; Hidalgo J
J Neurosci Res; 2003 Jun; 72(5):574-86. PubMed ID: 12749022
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo.
Lanza C; Morando S; Voci A; Canesi L; Principato MC; Serpero LD; Mancardi G; Uccelli A; Vergani L
J Neurochem; 2009 Sep; 110(5):1674-84. PubMed ID: 19619133
[TBL] [Abstract][Full Text] [Related]
18. Metallic gold beads in hyaluronic acid: a novel form of gold-based immunosuppression? Investigations of the immunosuppressive effects of metallic gold on cultured J774 macrophages and on neuronal gene expression in experimental autoimmune encephalomyelitis.
Pedersen DS; Tran TP; Smidt K; Bibby BM; Rungby J; Larsen A
Biometals; 2013 Jun; 26(3):369-85. PubMed ID: 23653168
[TBL] [Abstract][Full Text] [Related]
19. Ribavirin ameliorates experimental autoimmune encephalomyelitis in rats and modulates cytokine production.
Lavrnja I; Stojkov D; Bjelobaba I; Pekovic S; Dacic S; Nedeljkovic N; Mostarica-Stojkovic M; Stosic-Grujicic S; Rakic L; Stojiljkovic M
Int Immunopharmacol; 2008 Sep; 8(9):1282-90. PubMed ID: 18602075
[TBL] [Abstract][Full Text] [Related]
20. Metallothionein prevents neurodegeneration and central nervous system cell death after treatment with gliotoxin 6-aminonicotinamide.
Penkowa M; Quintana A; Carrasco J; Giralt M; Molinero A; Hidalgo J
J Neurosci Res; 2004 Jul; 77(1):35-53. PubMed ID: 15197737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
